Enliven Therapeutics Inc (ELVN)

Other Income/Expenses (Net)

$18.49M

TTM · Period ending: · USD

ELVN logo

ELVN Other Income/Expenses (Net)

Latest reported$18.49M
ELVN TTM Other Income/Expenses (Net) ($653.00K → $18.49M)
High-resolution chart · PNG

ELVN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Enliven Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
18,486,000
17,011,000
15,964,000
15,062,000
14,026,000
15,662,000
15,762,000
15,405,000
14,972,000
13,500,000
11,945,000
9,199,000
6,100,000
2,814,000
1,129,000
519,000
151,000
32,000
46,000
75,000
134,000
224,000
338,000
539,000
728,000
790,000
653,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.